Literature DB >> 25416133

Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming.

Li Wang1, Ziqing Liu1, Chaoying Yin1, Huda Asfour1, Olivia Chen1, Yanzhen Li1, Nenad Bursac1, Jiandong Liu1, Li Qian2.   

Abstract

RATIONALE: Generation of induced cardiac myocytes (iCMs) directly from fibroblasts offers great opportunities for cardiac disease modeling and cardiac regeneration. A major challenge of iCM generation is the low conversion rate of fibroblasts to fully reprogrammed iCMs, which could in part be attributed to unbalanced expression of reprogramming factors Gata4 (G), Mef2c (M), and Tbx5 (T) using the current gene delivery approach.
OBJECTIVE: We aimed to establish a system to express distinct ratios of G, M, T proteins in fibroblasts and determine the effect of G, M, T stoichiometry on iCM reprogramming. METHODS AND
RESULTS: We took advantage of the inherent feature of the polycistronic system and generated all possible combinations of G, M, T with identical 2A sequences in a single transgene. We demonstrated that each splicing order of G, M, T gave rise to distinct G, M, T protein expression levels. Combinations that resulted in higher protein level of Mef2c with lower levels of Gata4 and Tbx5 significantly enhanced reprogramming efficiency compared with separate G, M, T transduction. Importantly, after further optimization, the MGT vector resulted in more than 10-fold increase in the number of mature beating iCM loci. Molecular characterization revealed that more optimal G, M, T stoichiometry correlated with higher expression of mature cardiac myocyte markers.
CONCLUSIONS: Our results demonstrate that stoichiometry of G, M, T protein expression influences the efficiency and quality of iCM reprogramming. The established optimal G, M, T expression condition will provide a valuable platform for future iCM studies.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  Gata4 protein; Mef2c protein; Tbx5 protein; fibroblasts; gene expression/regulation; myocytes, cardiac; regeneration; transcription factors

Mesh:

Substances:

Year:  2014        PMID: 25416133      PMCID: PMC4299697          DOI: 10.1161/CIRCRESAHA.116.305547

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes.

Authors:  Tilanthi M Jayawardena; Bakytbek Egemnazarov; Elizabeth A Finch; Lunan Zhang; J Alan Payne; Kumar Pandya; Zhiping Zhang; Paul Rosenberg; Maria Mirotsou; Victor J Dzau
Journal:  Circ Res       Date:  2012-04-26       Impact factor: 17.367

2.  A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.

Authors:  Stephanie Protze; Shahryar Khattak; Claire Poulet; Dirk Lindemann; Elly M Tanaka; Ursula Ravens
Journal:  J Mol Cell Cardiol       Date:  2012-04-28       Impact factor: 5.000

3.  Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro.

Authors:  Li Qian; Emily C Berry; Ji-dong Fu; Masaki Ieda; Deepak Srivastava
Journal:  Nat Protoc       Date:  2013-05-30       Impact factor: 13.491

Review 4.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

5.  Reprogramming of human fibroblasts toward a cardiac fate.

Authors:  Young-Jae Nam; Kunhua Song; Xiang Luo; Edward Daniel; Kaleb Lambeth; Katherine West; Joseph A Hill; J Michael DiMaio; Linda A Baker; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

6.  Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.

Authors:  Kohei Inagawa; Kazutaka Miyamoto; Hiroyuki Yamakawa; Naoto Muraoka; Taketaro Sadahiro; Tomohiko Umei; Rie Wada; Yoshinori Katsumata; Ruri Kaneda; Koji Nakade; Chitose Kurihara; Yuichi Obata; Koichi Miyake; Keiichi Fukuda; Masaki Ieda
Journal:  Circ Res       Date:  2012-08-28       Impact factor: 17.367

7.  Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5.

Authors:  Jenny X Chen; Markus Krane; Marcus-Andre Deutsch; Li Wang; Moshe Rav-Acha; Serge Gregoire; Marc C Engels; Kuppusamy Rajarajan; Ravi Karra; E Dale Abel; Joe C Wu; David Milan; Sean M Wu
Journal:  Circ Res       Date:  2012-05-10       Impact factor: 17.367

8.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.

Authors:  Li Qian; Yu Huang; C Ian Spencer; Amy Foley; Vasanth Vedantham; Lei Liu; Simon J Conway; Ji-dong Fu; Deepak Srivastava
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

9.  Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming.

Authors:  Nicolas Christoforou; Malathi Chellappan; Andrew F Adler; Robert D Kirkton; Tianyi Wu; Russell C Addis; Nenad Bursac; Kam W Leong
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.

Authors:  Megumi Mathison; Robert P Gersch; Ahmed Nasser; Sarit Lilo; Mallory Korman; Mitchell Fourman; Neil Hackett; Kenneth Shroyer; Jianchang Yang; Yupo Ma; Ronald G Crystal; Todd K Rosengart
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

View more
  103 in total

1.  In vivo cardiac reprogramming using an optimal single polycistronic construct.

Authors:  Hong Ma; Li Wang; Chaoying Yin; Jiandong Liu; Li Qian
Journal:  Cardiovasc Res       Date:  2015-09-23       Impact factor: 10.787

Review 2.  Extracellular Matrix and Regenerative Therapies from the Cardiac Perspective.

Authors:  Arin Dogan; Mahmut Parmaksız; A Eser Elçin; Y Murat Elçin
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

3.  Comparative Gene Expression Analyses Reveal Distinct Molecular Signatures between Differentially Reprogrammed Cardiomyocytes.

Authors:  Yang Zhou; Li Wang; Ziqing Liu; Sahar Alimohamadi; Chaoying Yin; Jiandong Liu; Li Qian
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

Review 4.  Discovery and progress of direct cardiac reprogramming.

Authors:  Hidenori Kojima; Masaki Ieda
Journal:  Cell Mol Life Sci       Date:  2017-02-14       Impact factor: 9.261

5.  In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.

Authors:  Megumi Mathison; Vivek P Singh; Maria J Chiuchiolo; Deepthi Sanagasetti; Yun Mao; Vivekkumar B Patel; Jianchang Yang; Stephen M Kaminsky; Ronald G Crystal; Todd K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-23       Impact factor: 5.209

Review 6.  Synthetic development: building mammalian multicellular structures with artificial genetic programs.

Authors:  Marco Santorelli; Calvin Lam; Leonardo Morsut
Journal:  Curr Opin Biotechnol       Date:  2019-05-23       Impact factor: 9.740

Review 7.  Improving cardiac reprogramming for heart regeneration.

Authors:  Liu Liu; Ienglam Lei; Zhong Wang
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

Review 8.  Molecular discoveries and treatment strategies by direct reprogramming in cardiac regeneration.

Authors:  John H Werner; John H Rosenberg; John Y Um; Michael J Moulton; Devendra K Agrawal
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

9.  Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes.

Authors:  Ziqing Liu; Olivia Chen; Michael Zheng; Li Wang; Yang Zhou; Chaoying Yin; Jiandong Liu; Li Qian
Journal:  Stem Cell Res       Date:  2016-02-27       Impact factor: 2.020

10.  Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming.

Authors:  Haley Ruth Vaseghi; Chaoying Yin; Yang Zhou; Li Wang; Jiandong Liu; Li Qian
Journal:  Genesis       Date:  2016-06-01       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.